Clinical Trials List
Protocol NumberGO44154
NCT Number(ClinicalTrials.gov Identfier)-
2024-04-01 - 2024-05-06
Phase I
Terminated2
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/11
Investigators and Locations
Co-Principal Investigator
- 吳教恩 Division of Hematology & Oncology
- 呂嘉偉 Division of Radiology
- Wen-Chi Chou Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- 張俊偉 Division of Neurology
- Jen-Shi Chen Division of Hematology & Oncology
- 陳冠任 Division of Ophthalmology
- Tsai-Sheng Yang Division of Hematology & Oncology
- 闕宗熙 Division of Others
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Chia-Chi Lin
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- 徐思淳 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- 陳國興
- SHIH-HUNG YANG
- James Chih-Hsin Yang
- Kun-Huei Yeh Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Condition/Disease
-
Objectives
-
Test Drug
-
Active Ingredient
-
Dosage Form
-
Dosage
-
Endpoints
-
Inclution Criteria
-
Exclusion Criteria
-
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
44 participants